chr17-41055165-C-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_033032.3(KRTAP2-2):c.47G>C(p.Gly16Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033032.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000280 AC: 4AN: 142912Hom.: 0 Cov.: 19
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000161 AC: 2AN: 1244634Hom.: 0 Cov.: 22 AF XY: 0.00000164 AC XY: 1AN XY: 608572
GnomAD4 genome AF: 0.0000280 AC: 4AN: 142912Hom.: 0 Cov.: 19 AF XY: 0.0000145 AC XY: 1AN XY: 69202
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.47G>C (p.G16A) alteration is located in exon 1 (coding exon 1) of the KRTAP2-2 gene. This alteration results from a G to C substitution at nucleotide position 47, causing the glycine (G) at amino acid position 16 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at